Kura Oncology, Inc.
DE ˙ DB ˙ US50127T1097
7,56 € ↑0,24 (3,28%)
2026-06-05
DEL PRIS
SecurityDE:KUR / Kura Oncology, Inc.
InstitutionSei Investments Co
Latest Disclosed Ownership183,448 shares
Latest Disclosed Value $ 1,906,046
Sei Investments Co ownership in KUR / Kura Oncology, Inc.

On February 13, 2026 - Sei Investments Co filed a 13F-HR form disclosing ownership of 183,448 shares of Kura Oncology, Inc. (DE:KUR) valued at $1,597,832 USD as of December 31, 2025. The entity filed a previous 13F-HR on August 14, 2025 disclosing 0 shares of Kura Oncology, Inc.. The current value of the position is $1,386,867 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-02-13 2025-12-31 13F KURA ONCOLOGY COM 50127T109 183,448 183,448 1,906 0.0019
2025-08-14 2025-06-30 13F KURA ONCOLOGY COM 50127T109 0 -20,815 -100.00 0 -100.00
2025-05-13 2025-03-31 13F KURA ONCOLOGY COM 50127T109 20,815 0 0.00 181 0.00 0.0002
2025-02-11 2024-12-31 13F KURA ONCOLOGY COM 50127T109 20,815 6,055 41.02 181 -37.15 0.0002
2024-11-12 2024-09-30 13F KURA ONCOLOGY COM 50127T109 14,760 -355 -2.35 288 -7.40 0.0004
2024-08-13 2024-06-30 13F KURA ONCOLOGY COM 50127T109 15,115 -2,653 -14.93 311 -17.72 0.0004
2024-05-07 2024-03-31 13F KURA ONCOLOGY COM 50127T109 17,768 17,768 379 0.0006
2021-02-08 2020-12-31 13F KURA ONCOLOGY COM 50127T109 0 -23,353 -100.00 0 -100.00
2020-12-04 2020-09-30 13F/A-1 KURA ONCOLOGY COM 50127T109 23,353 23,353 716 0.0021
2020-11-06 2020-09-30 13F KURA ONCOLOGY COM 50127T109 23,353 23,353 716
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.